Avastin NOT recommended for BC
 

http://www.bloomberg.com/apps/news?p...bEw&refer=home

Dec. 5 (Bloomberg) -- Genentech Inc.'s Avastin, the drugmaker's second-biggest product, should be rejected for use against breast cancer, U.S. advisers said. Genentech fell the most in more than five years on the New York Stock Exchange before trading was halted.

Does anyone know if some insurance companies might still cover its use?